Previous close | 1.0000 |
Open | 0.9100 |
Bid | 0.8000 |
Ask | 1.0500 |
Strike | 20.00 |
Expiry date | 2024-08-16 |
Day's range | 0.9100 - 1.0000 |
Contract range | N/A |
Volume | |
Open interest | 63 |
Investors need to pay close attention to Organon (OGN) stock based on the movements in the options market lately.
When a stock breaks out above the 20-day simple moving average, good things could be on the horizon. How should investors react?
SHANGHAI, China & JERSEY CITY, N.J., May 24, 2024--European Medicines Agency validates Organon and Henlius marketing authorization filings for Prolia and Xgeva (denosumab) biosimilar candidate HLX14.